Nuvectis Pharma, Inc.
- NVCT
- NASDAQ
- Biotechnology
- Precision Oncology
- HSF1 Inhibitors
$18.60
Today −1.74%Quote Oct 16, 2026, 08:00 PM UTC
−13.00%over the last month
Max drawdown −21.7%From 1-month high −19.1%3 months +3.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$607.2M
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$37.33
+100.7% from here
Floor
$18.35
1.4% below price
Where the price sits
3 analysts
Analyst range, low to high
$33.00$40.00
- Price $18.60
- Resistance $19.73
- Consensus $37.33
The price is just above its floor. Analysts' average target sits about 101% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NVCTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
16